Transient receptor potential ankyrin 1 receptor stimulation by hydrogen peroxide is critical to trigger pain during monosodium urate-induced inflammation in rodents

Arthritis and Rheumatism

Volumn 65, Issue 11, 2013, Pages 2984-2995

  Trevisan, Gabriela ^a   Hoffmeister, Carin ^a   Rossato, Mateus F ^a   Oliveira, Sara M ^a   Silva, Mariane A ^a   Ineu, Rafael P ^a   Guerra, Gustavo P ^b   Materazzi, Serena ^c   Fusi, Camilla ^c   Nassini, Romina ^c   Geppetti, Pierangelo ^c   Ferreira, Juliano ^d  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

^c UNIVERSITY OF FLORENCE   (Italy)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CATALASE; DITHIOTHREITOL; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL AFFECTING AGENT; URATE; URIC ACID; VANILLOID RECEPTOR 1;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL INFILTRATION; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; EXPERIMENTAL MODEL; GENE DELETION; GOUT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY PAIN; MALE; NERVE CELL CULTURE; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ACETANILIDES; ACUTE PAIN; ANIMALS; ARTHRITIS, GOUTY; DISEASE MODELS, ANIMAL; HYDROGEN PEROXIDE; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; OXIDANTS; PURINES; RATS; RATS, WISTAR; SENSORY RECEPTOR CELLS; TRPC CATION CHANNELS; URIC ACID;

EID: 84886800978     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38112     Document Type: Article

References (49)

1. Terkeltaub R,. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010; 6: 30-8.
2. Richette P, Bardin T,. Gout. Lancet 2010; 375: 318-28.
3. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N,. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011; 17: 1-6.
4. Busso N, So A,. Mechanisms of inflammation in gout. Arthritis Res Ther 2010; 12: 206.
5. Moran MM, McAlexander MA, Biro T, Szallasi A,. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 2011; 10: 601-20.
6. Nilius B, Prenen J, Owsianik G,. Irritating channels: the case of TRPA1. J Physiol 2011; 589: 1543-9.
7. Baraldi PG, Preti D, Materazzi S, Geppetti P,. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem 2010; 53: 5085-107.
8. Hoffmeister C, Trevisan G, Rossato MF, de Oliveira SM, Gomez MV, Ferreira J,. Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats. Pain 2011; 152: 1777-88.
9. Krishnan E,. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 2010; 49: 1229-38.
10. Falasca GF, Ramachandrula A, Kelley KA, O'Connor CR, Reginato AJ,. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 1993; 36: 105-16.
11. Abramson S, Hoffstein ST, Weissmann G,. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum 1982; 25: 174-80.
12. Thomas MJ,. Urate causes the human polymorphonuclear leukocyte to secrete superoxide. Free Radic Biol Med 1992; 12: 89-91.
13. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 2007; 104: 13519-24.
14. Andrade EL, Meotti FC, Calixto JB,. TRPA1 antagonists as potential analgesic drugs. Pharmacol Ther 2012; 133: 189-204.
15. Del Camino D, Murphy S, Heiry M, Barrett LB, Earley TJ, Cook CA, et al. TRPA1 contributes to cold hypersensitivity. J Neurosci 2010; 30: 15165-74.
16. Schwartz ES, Christianson JA, Chen X, La JH, Davis BM, Albers KM, et al. Synergistic role of TRPV1 and TRPA1 in pancreatic pain and inflammation. Gastroenterology 2011; 140: 1283-91.e1-2.
17. Salas MM, Hargreaves KM, Akopian AN,. TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1. Eur J Neurosci 2009; 29: 1568-78.
18. Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A,. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One 2009; 4: e7596.
19. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006; 124: 1269-82.
20. Zimmermann M,. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
21. Andre E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, et al. Cigarette smoke-induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 2008; 118: 2574-82.
22. Andrade EL, Luiz AP, Ferreira J, Calixto JB,. Pronociceptive response elicited by TRPA1 receptor activation in mice. Neuroscience 2008; 152: 511-20.
23. Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N, et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain 2011; 152: 1621-31.
24. Flatters SJ, Bennett GJ,. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004; 109: 150-61.
25. Nassini R, Materazzi S, Andre E, Sartiani L, Aldini G, Trevisani M, et al. Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J 2010; 24: 4904-16.
26. Ferreira J, da Silva GL, Calixto JB,. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 2004; 141: 787-94.
27. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005; 1: 3.
28. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
29. Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, Martinez-Augustin O, et al. Reversible ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 2010; 401: 318-20.
30. Andre E, Ferreira J, Malheiros A, Yunes RA, Calixto JB,. Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats. Neuropharmacology 2004; 46: 590-7.
31. Nakamura Y, Murakami A, Ohto Y, Torikai K, Tanaka T, Ohigashi H,. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′-acetoxychavicol acetate. Cancer Res 1998; 58: 4832-9.
32. Andersson DA, Gentry C, Moss S, Bevan S,. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 2008; 28: 2485-94.
33. Goyal MM, Basak A,. Human catalase: looking for complete identity. Protein Cell 2011; 1: 888-97.
34. Sawada Y, Hosokawa H, Matsumura K, Kobayashi S,. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide. Eur J Neurosci 2008; 27: 1131-42.
35. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004; 24: 4293-9.
36. Takahashi N, Mizuno Y, Kozai D, Yamamoto S, Kiyonaka S, Shibata T, et al. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. Channels (Austin) 2008; 2: 287-98.
37. Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF, et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007; 445: 541-5.
38. Malawista SE, de Boisfleury AC, Naccache PH,. Inflammatory gout: observations over a half-century. FASEB J 2011; 25: 4073-8.
39. Dorwart BB,. Thomas sydenham (1624-1689), on gout: 1717. J Clin Rheumatol 2004; 10: 227.
40. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003; 112: 819-29.
41. Da Costa DS, Meotti FC, Andrade EL, Leal PC, Motta EM, Calixto JB,. The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation. Pain 2010; 148: 431-7.
42. Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis 2009; 68: 1602-8.
43. Hatano N, Itoh Y, Suzuki H, Muraki Y, Hayashi H, Onozaki K, et al. Hypoxia-inducible factor-1α (HIF1α) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like motif to modulate cytokine release. J Biol Chem 2012; 287: 31962-72.
44. Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008; 29: 807-18.
45. Rock KL, Kataoka H, Lai JJ,. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2012; 9: 13-23.
46. Keeble JE, Bodkin JV, Liang L, Wodarski R, Davies M, Fernandes ES, et al. Hydrogen peroxide is a novel mediator of inflammatory hyperalgesia, acting via transient receptor potential vanilloid 1-dependent and independent mechanisms. Pain 2009; 141: 135-42.
47. Fernandes ES, Fernandes MA, Keeble JE,. The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 2012; 166: 510-21.
48. Chuang HH, Lin S,. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc Natl Acad Sci U S A 2009; 106: 20097-102.
49. Patil MJ, Jeske NA, Akopian AN,. Transient receptor potential V1 regulates activation and modulation of transient receptor potential A1 by Ca2+. Neuroscience 2010; 171: 1109-19.